* Provide remote training courses covering the latest colorectal cancer screening guidelines, methods for identifying high-risk individuals and their standards of care, as well as dietary intervention strategies.
* Offer ongoing support services, such as regular knowledge updates and technical consultations.

Remote training courses covering the latest CRC screening guidelines, identification of high-risk individuals and their standard of care, and dietary intervention strategies.

Ongoing support services, such as regular knowledge updates and technical consultations.

Remote training courses covering the latest CRC screening guidelines, identification of high-risk individuals and their standard of care, and dietary intervention strategies. Ongoing support services,

Current opportunistic screening practices within the rural primary healthcare system.

Continuation of routine healthcare services without any additional training interventions.

The First Affiliated Hospital with Nanjing Medical University

Colorectal cancer: Tunlametinib 6/9mg bid+ cetuximab β 500mg/m2

Colorectal cancer: Tunlametinib + cetuximab β

Pancreatic cancer: Tunlametinib 6/9mg+ cetuximab β 500mg/m2

Pancreatic cancer: Tunlametinib + cetuximab β

Pancreatic cancer: Tunlametinib 6/9mg bid +Nimotuzumab 400mg

Pancreatic cancer: Tunlametinib +Nimotuzumab

6 months of mHealth Colorectal cancer educational messages. The content will address elements such as activating and educating patients, exploring and removing challenges, accommodating personal goals, and engaging and targeting subgroups. Texts will be delivered to encourage cancer screenings and lifestyle changes, and participants will receive appointment reminders before each appointment with a follow-up text and robocall if the appointment is missed.

Specific colorectal cancer educational SMS text messages are sent to participants' mobile phones

mHealth for Colorectal cancer screening in Homeless Persons

6 months of mHealth, including basic healthcare and general health promotion via SMS texts that do not overlap with CRC screening content.

Standard health information SMS text messages sent to participants' mobile phones

Control SMS Messages

Ramin Asgary, MD, MPH

Multimodal ablation combined with cadonilimab and fruquintinib

MTT(Multimodal Tumor Thermal Therapy System)- Colorectal Cancer

Multimodal ablation combined with pucotenlimab and TPC or sacituzumab govitecan, eribulin,gemcitabine,UTD1

MTT(Multimodal Tumor Thermal Therapy System)- Triple-Negative Breast Cancer

Multimodal ablation combined with pucotenlimab, with other specific agents determined based on the first-line treatment regimen and the melanoma subtype.

MTT(Multimodal Tumor Thermal Therapy System)- Melanoma

Hongxia Wang

SMS reminders will be sent to individuals who received an invitation letter from Colorectal Cancer Screening Program and haven't participated within 6 weeks.

Individual randomization will be used. Individuals assigned to the experimental arm with a wrong phone number will get a reminder letter (protocol analysis).

SMS reminders to enhance colorectal cancer screening

Reminder letters will be sent to individuals who received an invitation letter from the Colorectal Cancer Screening Program and haven't participated within 6 weeks.

SMS reminders will be sent to individuals who picked the fecal immunochemical test at the pharmacy and haven't returned it within 14 days.

Individual randomization will be used. Individuals with a wrong phone number assigned to the experimental arm will not get any reminder (protocol analysis).

SMS reminders to return the fecal immunochemical test at the pharmacy in CRC screening:

Invitation by SMS will be sent to women who previously participated in the Breast Cancer Screening Program.

Individual randomization. Women assigned to the experimental arm and with a wrong phone number will get an invitation letter (protocol analysis).

Invitation by SMS to previous participants in breast cancer screening:

Intervention 1 and 2: both sexes. Intervention 3: only women.

The study staff will administer to eligible participants the pre-INT and post-INT surveys. The post-INT surveys will be administered approximately 8 months after delivering the INTs. The participants will receive the INT(s) immediately after completing the pre-INT surveys.

Adult men and women will receive age- and gender-specific INTs. Women age 45-75 years will receive the interventions for breast, colorectal, and cervical cancers screening. Men age 45-75 years will receive the intervention for colorectal cancer screening. Women age 21-49 years will receive the intervention for cervical cancer screening. The cognitive-behavioral INTs on age-gender specific cancers will range from 1-2 hours. The study team will utilize a digital flipchart that will cover each cancer's specific risk/protective factors, incidence, mortality, screening methods, and resources. The study team member delivering the INTs will function as a facilitator linking information with practical skills.

Aim 8 (INT, Pilot Test): Breast, Colorectal, and Cervical Cancer Screening Cognitive-Behavioral Interventions

Up to 200 physicians and other health professionals

Investigators will answer surveys about their lung cancer screening practices

Surveys

Up to 20 participants who speak English or Spanish

Participants will participate in focus groups about information they need in order to decide about lung cancer screening

Focus groups

Up to 40 participants who speak English or Spanish

Participants will participate in interviews about their understanding of the adapted video script

Cognitive Interviews

Up to 50 participants (25 English speakers, 25 Spanish speakers)

Participants take surveys before and after watching the intervention video

Lung cancer screening decision aid video

Participants take surveys before and after watching the control video

Colon cancer screening video

Robert Volk, PHD

standard chemotherapy for colorectal cancer

Nurse practitioner consultation will be done standard chemotherapy for colorectal cancer

Nurse practitioner consultation

Medical practitioner consultation will be done standard chemotherapy for colorectal cancer.

Medical practitioner consultation

Enrolled participants will watch three educational videos in Spanish pertaining to: (1) Colorectal Cancer (CRC) symptoms; (2) CRC risk factors and (3) CRC facts, screening, treatment, and Cancer Clinical Trials (CCT).

Enrolled participants will watch three educational videos on Colorectal Cancer (CRC) in Spanish. Knowledge on CRC symptoms, risk factors, facts, screening and treatment will be assessed before and immediately after the educational video and at 30 +/- 7 days. In addition, the association between increase in CRC knowledge and willingness to participate in Cancer Clinical Trials (CCT) will be explored.

Colorectal Cancer Educational Videos in Spanish

University of North Carolina, Chapel Hill

Single arm, open-label, pre-test/post-test design pilot trial

Using a single arm, open-label, pre-test post-test design (n=15 adult child/parent dyads), assess the impact of a young adult-mediated intervention to increase CRC screening among a paired age-eligible family member (e.g., parent/grandparent). The focus of the intervention will be on changes in CRC screening awareness and intentions among the age-eligible adult, but we hypothesize that the young adult could benefit as well. Thus, in addition to assessing feasibility and acceptability, we will assess changes in 1) CRC screening intentions among the age-eligible adults and 2) CRC health literacy and awareness of screening guidelines among the younger adult participant.

최신 대장암 검진 지침, 고위험군 식별 및 표준 치료, 식이요법 전략 등을 다루는 원격 교육 과정. 지속적인 지원 서비스 및 추가 교육 없이 기존 의료 서비스 지속 제공.

대장암: 툰라메티닙 + 세툭시맙 β, 췌장암: 툰라메티닙 + 세툭시맙 β, 췌장암: 툰라메티닙 + 니모투주맙

노숙자 대장암 검진을 위한 mHealth, SMS 메시지 제어

MTT(다중모드 종양 열 치료 시스템)- 대장암, MTT(다중모드 종양 열 치료 시스템)- 삼중 음성 유방암, MTT(다중모드 종양 열 치료 시스템)- 흑색종

대장암검진 강화를 위한 SMS 알림, 대장암 검진 시 약국에서 대변 면역화학 검사를 반납하라는 SMS 알림, 유방암 검진에 참여한 이전 참가자에게 SMS로 초대:

목표 8(INT, 파일럿 테스트): 유방암, 대장암, 자궁경부암 검진을 위한 인지행동적 개입

설문조사, 포커스 그룹, 인지 인터뷰, 폐암 검진 결정 지원 영상, 대장암 검진 영상

대장암 표준 항암화학요법, 간호사 상담, 의사 상담

대장암 교육 영상 (스페인어)

대장암 검진에 대한 인식 및 의향의 변화